HIV / AIDS Pipeline Review and Market Research, H1 2015

This report provides comprehensive information on the therapeutic development for HIV / AIDS, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for HIV / AIDS and special features on late-stage and discontinued projects. Get a copy of this report at . (This is a premium report price at US$2500 for a single user PDF license)

Some of the Company profiles mentioned in this report are Altor BioScience Corporation American Gene Technologies International Inc., BioClonetics Immunotherapeutics, Bristol-Myers Squibb Company, DNAVEC Corporation, Fountain Biopharma Inc., Hadasit Medical Research Services & Development Ltd, Johnson & Johnson, Laila Pharmaceuticals Pvt. Ltd., Mymetics Corporation, Omeros Corporation, Orbis Biosciences, Inc.


- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for HIV / AIDS and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the HIV / AIDS products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.